Company · CIK 0001628738 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Audentes Therapeutics, Inc. · BOLD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2019 SForm 4 → | Feb 27, 4:32 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | $30.06 | $300,553 | 18,236 | −35.4% | plan? |
| Feb 25, 2019 MForm 4 → | Feb 27, 4:32 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | $0.79 | $7,900 | 28,236 | — | plan? |
| Feb 25, 2019 SForm 4 → | Feb 27, 4:31 pm EST | Matthew R PattersonChief Executive Officer, Director | 21,000 | $30.00 | $630,000 | 118,700 | −15.0% | plan? |
| Feb 25, 2019 MForm 4 → | Feb 27, 4:31 pm EST | Matthew R PattersonChief Executive Officer, Director | 21,000 | $1.05 | $22,020 | 122,700 | — | plan? |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:50 pm EST | Matthew R PattersonChief Executive Officer, Director | 63,700 | — | — | 118,700 | — | plan? |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:29 pm EST | Thomas P SolowayExecutive Vice President, CFO | 23,333 | — | — | 23,333 | — | plan? |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:25 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 17,500 | — | — | 18,236 | — | plan? |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:20 pm EST | Natalie C. HollesPresident and COO | 23,333 | — | — | 56,723 | — | plan? |
| Jan 24, 2019 MForm 4 → | Jan 25, 7:28 pm EST | Natalie C. HollesPresident and COO | 8,300 | $2.76 | $22,949 | 33,390 | — | plan? |
| Dec 24, 2018 SForm 4 → | Dec 27, 5:43 pm EST | Louis G LangeDirector | 32,000 | $18.62 | $595,799 | 32,343 | −49.7% | plan? |
| Dec 6, 2018 MForm 4 → | Dec 10, 4:39 pm EST | Matthew R PattersonChief Executive Officer, Director | 40,000 | $0.78 | $31,200 | 55,000 | — | plan? |
| Nov 15, 2018 AForm 4 → | Nov 16, 6:41 pm EST | Mary NewmanSVP, Regulatory Affairs | 660 | $19.64 | $12,959 | 660 | — | plan? |
| Nov 15, 2018 AForm 4 → | Nov 16, 6:37 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 736 | $19.64 | $14,451 | 736 | — | plan? |
| Nov 15, 2018 SForm 4 → | Nov 16, 6:34 pm EST | Louis G LangeDirector | 24,000 | $22.49 | $539,760 | 3,555 | −87.1% | plan? |
| Oct 1, 2018 SForm 4 → | Oct 2, 7:05 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | $36.88 | $368,788 | 0 | −100% | plan? |
| Oct 1, 2018 MForm 4 → | Oct 2, 7:05 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | $0.79 | $7,900 | 4,699 | — | plan? |
| Oct 1, 2018 SForm 4 → | Oct 2, 7:04 pm EDT | Matthew R PattersonChief Executive Officer, Director | 21,000 | $38.16 | $801,372 | 15,000 | −58.3% | plan? |
| Oct 1, 2018 MForm 4 → | Oct 2, 7:04 pm EDT | Matthew R PattersonChief Executive Officer, Director | 21,000 | $0.78 | $16,380 | 23,078 | — | plan? |
| Sep 28, 2018 SForm 4 → | Oct 2, 7:03 pm EDT | John T. GraySVP, Chief Scientific Officer | 87 | $40.00 | $3,480 | 0 | −100% | plan? |
| Sep 28, 2018 MForm 4 → | Oct 2, 7:03 pm EDT | John T. GraySVP, Chief Scientific Officer | 87 | $1.05 | $91 | 87 | — | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 7:00 pm EDT | Louis G LangeDirector | 33,000 | $37.38 | $1,233,381 | 42,343 | −43.8% | plan? |
| Sep 24, 2018 MForm 4 → | Sep 24, 6:12 pm EDT | Matthew R PattersonChief Executive Officer, Director | 15,000 | $0.78 | $11,700 | 15,000 | — | plan? |
| Sep 18, 2018 SForm 4 → | Sep 20, 7:01 pm EDT | Matthew R PattersonChief Executive Officer, Director | 12,952 | $40.00 | $518,080 | 0 | −100% | plan? |
| Sep 18, 2018 MForm 4 → | Sep 20, 7:01 pm EDT | Matthew R PattersonChief Executive Officer, Director | 12,952 | $2.19 | $28,365 | 12,952 | — | plan? |
| Jul 2, 2018 SForm 4 → | Jul 5, 6:35 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | $38.41 | $384,067 | 0 | −100% | plan? |
| Jul 2, 2018 MForm 4 → | Jul 5, 6:35 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | $0.79 | $7,900 | 5,011 | — | plan? |
| Jul 2, 2018 SForm 4 → | Jul 5, 6:34 pm EDT | Matthew R PattersonChief Executive Officer, Director | 71,048 | $39.55 | $2,809,837 | 0 | −100% | plan? |
| Jul 2, 2018 MForm 4 → | Jul 5, 6:34 pm EDT | Matthew R PattersonChief Executive Officer, Director | 71,048 | $0.78 | $55,417 | 23,147 | — | plan? |
| Jun 25, 2018 SForm 4 → | Jun 27, 6:52 pm EDT | Mary NewmanSVP, Regulatory Affairs | 8,545 | $40.79 | $348,581 | 0 | −100% | plan? |
| Jun 25, 2018 MForm 4 → | Jun 27, 6:52 pm EDT | Mary NewmanSVP, Regulatory Affairs | 8,545 | $2.19 | $18,673 | 300 | — | plan? |
| Jun 25, 2018 SForm 4 → | Jun 27, 6:51 pm EDT | Louis G LangeDirector | 33,000 | $40.59 | $1,339,498 | 52,343 | −38.7% | plan? |
| Jun 20, 2018 SForm 4 → | Jun 22, 7:11 pm EDT | David NaglerSVP, HR & Corp. Affairs | 5,000 | $45.29 | $226,461 | 0 | −100% | plan? |
| Jun 20, 2018 MForm 4 → | Jun 22, 7:11 pm EDT | David NaglerSVP, HR & Corp. Affairs | 5,000 | $2.19 | $10,926 | 300 | — | plan? |
| Jun 1, 2018 MForm 4 → | Jun 4, 4:48 pm EDT | Natalie C. HollesPresident and COO | 5,090 | $2.76 | $14,073 | 25,090 | — | plan? |
| May 21, 2018 SForm 4 → | May 23, 6:13 pm EDT | Matthew R PattersonPresident & CEO, Director | 20,300 | $38.15 | $774,498 | 0 | −100% | plan? |
| May 21, 2018 MForm 4 → | May 23, 6:13 pm EDT | Matthew R PattersonPresident & CEO, Director | 20,300 | $0.78 | $15,834 | 6,700 | — | plan? |
| Apr 2, 2018 SForm 4 → | Apr 4, 9:01 pm EDT | Matthew R PattersonPresident & CEO, Director | 700 | $30.01 | $21,009 | 0 | −100% | plan? |
| Apr 2, 2018 MForm 4 → | Apr 4, 9:01 pm EDT | Matthew R PattersonPresident & CEO, Director | 700 | $0.78 | $546 | 700 | — | plan? |
| Mar 29, 2018 MForm 4 → | Mar 29, 8:23 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 7,800 | $0.79 | $6,162 | 7,800 | — | plan? |
| Mar 26, 2018 MForm 4 → | Mar 28, 9:12 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 2,200 | $0.79 | $1,738 | 300 | — | plan? |
| Mar 26, 2018 SForm 4 → | Mar 28, 9:11 pm EDT | Louis G LangeDirector | 48,000 | $28.89 | $1,386,937 | 62,343 | −43.5% | plan? |
| Mar 15, 2018 SForm 4 → | Apr 2, 9:06 pm EDT | Mary NewmanSVP, Regulatory Affairs | 10,000 | $30.36 | $303,627 | 0 | −100% | plan? late |
| Mar 15, 2018 MForm 4 → | Apr 2, 9:06 pm EDT | Mary NewmanSVP, Regulatory Affairs | 10,000 | $2.19 | $21,900 | 400 | — | plan? late |
| Mar 8, 2018 SForm 4 → | Mar 12, 6:16 pm EDT | ORBIMED ADVISORS LLC +110% Owner | 156,431 | $34.97 | $5,469,926 | 3,539,997 | −4.23% | plan? |
| Mar 2, 2018 SForm 4 → | Mar 6, 5:53 pm EST | ORBIMED ADVISORS LLC +110% Owner | 433,210 | $35.11 | $15,210,616 | 3,696,428 | −10.5% | plan? |
| Jan 3, 2018 AForm 4 → | Jan 4, 2019, 4:48 pm EST | Eric MosbrookerSVP, Chief Commercial Officer | 31,500 | — | — | 31,800 | — | plan? late |
| Dec 22, 2017 SForm 4 → | Dec 26, 7:38 pm EST | Louis G LangeDirector | 18,000 | $30.88 | $555,792 | 4,558 | −79.8% | plan? |
| Dec 1, 2017 SForm 4 → | Dec 5, 4:00 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 8,000 | $28.53 | $228,264 | 0 | −100% | plan? |
| Dec 1, 2017 MForm 4 → | Dec 5, 4:00 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 8,000 | $0.79 | $6,320 | 1,230 | — | plan? |
| Nov 16, 2017 SForm 4 → | Nov 17, 5:06 pm EST | Mary NewmanSVP, Regulatory Affairs | 10,000 | $26.84 | $268,375 | 0 | −100% | plan? |
| Nov 16, 2017 MForm 4 → | Nov 17, 5:06 pm EST | Mary NewmanSVP, Regulatory Affairs | 10,000 | $2.19 | $21,900 | 4,260 | — | plan? |
| Oct 2, 2017 SForm 4 → | Oct 4, 8:25 pm EDT | Matthew R PattersonPresident & CEO, Director | 25,000 | $27.92 | $698,070 | 171,814 | −12.7% | plan? |
| Oct 2, 2017 MForm 4 → | Oct 4, 8:25 pm EDT | Matthew R PattersonPresident & CEO, Director | 10,000 | $0.78 | $7,800 | 10,000 | — | plan? |
| Sep 29, 2017 SForm 4 → | Sep 29, 6:06 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 672,000 | $28.25 | $18,984,000 | 4,129,638 | −14.0% | plan? |
| Sep 29, 2017 SForm 4 → | Sep 29, 5:47 pm EDT | Louis G LangeDirector | 11,000 | $28.35 | $311,903 | 5,558 | −66.4% | plan? |
| Sep 27, 2017 SForm 4 → | Sep 29, 5:48 pm EDT | David NaglerSVP, HR & Corp. Affairs | 3,750 | $30.00 | $112,500 | 0 | −100% | plan? |
| Sep 27, 2017 MForm 4 → | Sep 29, 5:48 pm EDT | David NaglerSVP, HR & Corp. Affairs | 3,750 | $2.19 | $8,195 | 3,750 | — | plan? |
| Sep 25, 2017 SForm 4 → | Sep 26, 5:44 pm EDT | Louis G LangeDirector | 18,000 | $28.32 | $509,727 | 7,558 | −70.4% | plan? |
| Sep 15, 2017 SForm 4 → | Sep 19, 6:00 pm EDT | Matthew R PattersonPresident & CEO, Director | 10,000 | $25.06 | $250,561 | 0 | −100% | plan? |
| Sep 15, 2017 MForm 4 → | Sep 19, 6:00 pm EDT | Matthew R PattersonPresident & CEO, Director | 10,000 | $0.78 | $7,800 | 8,458 | — | plan? |
| Sep 15, 2017 SForm 4 → | Sep 19, 5:59 pm EDT | David NaglerSVP, HR & Corp. Affairs | 3,750 | $25.00 | $93,750 | 0 | −100% | plan? |
| Sep 15, 2017 MForm 4 → | Sep 19, 5:59 pm EDT | David NaglerSVP, HR & Corp. Affairs | 3,750 | $2.19 | $8,195 | 3,750 | — | plan? |
| Sep 7, 2017 SForm 4 → | Sep 11, 2:16 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 5,000 | $22.35 | $111,750 | 4,801,638 | −0.10% | plan? |
| Sep 7, 2017 XForm 4 → | Sep 11, 2:16 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 5,000 | $15.03 | $75,150 | 4,806,638 | — | plan? |
| Sep 1, 2017 SForm 4 → | Sep 1, 5:55 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 8,000 | $21.44 | $171,481 | 0 | −100% | plan? |
| Sep 1, 2017 MForm 4 → | Sep 1, 5:55 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 8,000 | $0.79 | $6,320 | 8,000 | — | plan? |
| Aug 24, 2017 SForm 4 → | Aug 25, 4:17 pm EDT | Mary NewmanSVP, Regulatory Affairs | 10,000 | $20.00 | $200,000 | 0 | −100% | plan? |
| Aug 24, 2017 MForm 4 → | Aug 25, 4:17 pm EDT | Mary NewmanSVP, Regulatory Affairs | 10,000 | $2.19 | $21,900 | 10,000 | — | plan? |
| Jul 12, 2017 SForm 4 → | Jul 14, 8:01 pm EDT | Matthew R PattersonPresident & CEO, Director | 15,000 | $20.00 | $300,059 | 186,814 | −7.43% | plan? |
| Jun 26, 2017 SForm 4 → | Jun 28, 4:42 pm EDT | Louis G LangeDirector | 15,000 | $19.78 | $296,682 | 460,799 | −3.15% | plan? |
| May 31, 2017 MForm 4 → | Jun 1, 4:31 pm EDT | Natalie C. HollesSenior Vice President, COO | 20,000 | $2.76 | $55,200 | 20,000 | — | plan? |
| Apr 24, 2017 PForm 4 → | Apr 26, 8:17 pm EDT | 5AM Partners III, LLC +5Other | 172,413 | $14.50 | $2,499,989 | 2,500,113 | +7.41% | plan? |
| Mar 29, 2017 SForm 4 → | Mar 29, 2018, 8:23 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 7,800 | $30.03 | $234,195 | 0 | −100% | plan? late |
| Mar 27, 2017 SForm 4 → | Mar 28, 2018, 9:12 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 2,200 | $30.00 | $66,000 | 0 | −100% | plan? late |
| Jul 25, 2016 PForm 4 → | Jul 25, 5:09 pm EDT | Thomas WoiwodeDirector | 35,000 | $15.00 | $525,000 | 11,308 | — | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:09 pm EDT | Thomas WoiwodeDirector | 1,771,832 | — | — | 11,089 | — | plan? |
| Jul 25, 2016 PForm 4 → | Jul 25, 5:08 pm EDT | Versant Ventures IV, LLC10% Owner | 35,000 | $15.00 | $525,000 | 11,308 | — | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:08 pm EDT | Versant Ventures IV, LLC10% Owner | 1,771,832 | — | — | 11,089 | — | plan? |
| Jul 25, 2016 PForm 4 → | Jul 25, 5:08 pm EDT | Jonathan SilversteinDirector, 10% Owner | 33,334 | $15.00 | $500,010 | 4,801,638 | +0.70% | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:08 pm EDT | Jonathan SilversteinDirector, 10% Owner | 4,544,066 | — | — | 4,768,304 | — | plan? |
| Jul 25, 2016 PForm 4 → | Jul 25, 5:07 pm EDT | ORBIMED ADVISORS LLCDirector, 10% Owner | 33,334 | $15.00 | $500,010 | 4,801,638 | +0.70% | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:07 pm EDT | ORBIMED ADVISORS LLCDirector, 10% Owner | 4,544,066 | — | — | 4,768,304 | — | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:07 pm EDT | Louis G LangeDirector | 24,633 | — | — | 14,555 | — | plan? |
| Jul 25, 2016 PForm 4 → | Jul 25, 5:06 pm EDT | 5AM Partners III, LLC10% Owner | 70,000 | $15.00 | $1,050,000 | 60,100 | — | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:06 pm EDT | 5AM Partners III, LLC10% Owner | 2,322,131 | — | — | 58,341 | — | plan? |
| Jul 25, 2016 PForm 4 → | Jul 25, 12:19 pm EDT | James E Flynn +510% Owner | 400,000 | $15.00 | $6,000,000 | 514,424 | +350% | plan? |
| Jul 25, 2016 CForm 4 → | Jul 25, 12:19 pm EDT | James E Flynn +510% Owner | 1,003,654 | — | — | 367,828 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2019 MForm 4 → | Feb 27, 4:32 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | — | — | 40,870 | — | |
| Feb 25, 2019 MForm 4 → | Feb 27, 4:31 pm EST | Matthew R PattersonChief Executive Officer, Director | 21,000 | — | — | 74,297 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:50 pm EST | Matthew R PattersonChief Executive Officer, Director | 177,450 | — | — | 177,450 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:29 pm EST | Thomas P SolowayExecutive Vice President, CFO | 65,000 | — | — | 65,000 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:28 pm EST | Julie SmithDirector | 16,200 | — | — | 16,200 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:27 pm EST | Thomas J. SchuetzDirector | 16,200 | — | — | 16,200 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:25 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 48,750 | — | — | 48,750 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:23 pm EST | Scott W MorrisonDirector | 16,200 | — | — | 16,200 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:22 pm EST | Louis G LangeDirector | 16,200 | — | — | 16,200 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:21 pm EST | Jennifer JarrettDirector | 16,200 | — | — | 16,200 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:20 pm EST | Natalie C. HollesPresident and COO | 65,000 | — | — | 65,000 | — | |
| Feb 6, 2019 AForm 4 → | Feb 8, 5:20 pm EST | Mark Alan GoldbergDirector | 16,200 | — | — | 16,200 | — | |
| Jan 24, 2019 MForm 4 → | Jan 25, 7:28 pm EST | Natalie C. HollesPresident and COO | 8,300 | — | — | 156,429 | — | |
| Jan 3, 2019 AForm 4 → | Jan 4, 4:48 pm EST | Eric MosbrookerSVP, Chief Commercial Officer | 87,750 | — | — | 87,750 | — | |
| Dec 6, 2018 MForm 4 → | Dec 10, 4:39 pm EST | Matthew R PattersonChief Executive Officer, Director | 40,000 | — | — | 31,702 | — | |
| Oct 1, 2018 MForm 4 → | Oct 2, 7:05 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | — | — | 50,870 | — | |
| Oct 1, 2018 MForm 4 → | Oct 2, 7:04 pm EDT | Matthew R PattersonChief Executive Officer, Director | 21,000 | — | — | 71,702 | — | |
| Sep 28, 2018 MForm 4 → | Oct 2, 7:03 pm EDT | John T. GraySVP, Chief Scientific Officer | 87 | — | — | 71,669 | — | |
| Sep 24, 2018 MForm 4 → | Sep 24, 6:12 pm EDT | Matthew R PattersonChief Executive Officer, Director | 15,000 | — | — | 92,702 | — | |
| Sep 18, 2018 MForm 4 → | Sep 20, 7:01 pm EDT | Matthew R PattersonChief Executive Officer, Director | 12,952 | — | — | 128,345 | — | |
| Jul 2, 2018 MForm 4 → | Jul 5, 6:35 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 10,000 | — | — | 60,870 | — | |
| Jul 2, 2018 MForm 4 → | Jul 5, 6:34 pm EDT | Matthew R PattersonChief Executive Officer, Director | 71,048 | — | — | 107,702 | — | |
| Jun 25, 2018 MForm 4 → | Jun 27, 6:52 pm EDT | Mary NewmanSVP, Regulatory Affairs | 8,545 | — | — | 15,272 | — | |
| Jun 20, 2018 MForm 4 → | Jun 22, 7:11 pm EDT | David NaglerSVP, HR & Corp. Affairs | 5,000 | — | — | 32,347 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:24 pm EDT | Julie SmithDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:23 pm EDT | Thomas J. SchuetzDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:23 pm EDT | Kush ParmarDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:22 pm EDT | Scott W MorrisonDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:21 pm EDT | Louis G LangeDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:21 pm EDT | Jennifer JarrettDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 8, 5:20 pm EDT | Mark Alan GoldbergDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 MForm 4 → | Jun 4, 4:48 pm EDT | Natalie C. HollesPresident and COO | 5,090 | — | — | 164,729 | — | |
| May 21, 2018 MForm 4 → | May 23, 6:13 pm EDT | Matthew R PattersonPresident & CEO, Director | 20,300 | — | — | 178,750 | — | |
| May 7, 2018 AForm 4 → | May 8, 8:08 am EDT | Natalie C. HollesPresident and COO | 25,000 | — | — | 25,000 | — | |
| Apr 2, 2018 MForm 4 → | Apr 4, 9:01 pm EDT | Matthew R PattersonPresident & CEO, Director | 700 | — | — | 199,050 | — | |
| Mar 29, 2018 MForm 4 → | Mar 29, 8:23 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 7,800 | — | — | 70,870 | — | |
| Mar 26, 2018 MForm 4 → | Mar 28, 9:12 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 2,200 | — | — | 78,670 | — | |
| Mar 15, 2018 MForm 4 → | Apr 2, 9:06 pm EDT | Mary NewmanSVP, Regulatory Affairs | 10,000 | — | — | 23,817 | — | late |
| Jan 1, 2018 AForm 4 → | Jan 19, 5:11 pm EST | Mark Alan GoldbergDirector | 22,500 | — | — | 4,500 | — | late |
| Dec 1, 2017 MForm 4 → | Dec 5, 4:00 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 8,000 | — | — | 80,870 | — | |
| Nov 16, 2017 AForm 4 → | Nov 17, 5:09 pm EST | Thomas P SolowaySenior Vice President, CFO | 75,000 | — | — | 75,000 | — | |
| Nov 16, 2017 AForm 4 → | Nov 17, 5:07 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 75,000 | — | — | 75,000 | — | |
| Nov 16, 2017 AForm 4 → | Nov 17, 5:07 pm EST | Matthew R PattersonPresident & CEO, Director | 225,000 | — | — | 225,000 | — | |
| Nov 16, 2017 AMForm 4 → | Nov 17, 5:06 pm EST | Mary NewmanSVP, Regulatory Affairs | 60,000 | — | — | 50,000 | — | |
| Nov 16, 2017 AForm 4 → | Nov 17, 5:05 pm EST | David NaglerSVP, HR & Corp. Affairs | 50,000 | — | — | 50,000 | — | |
| Nov 16, 2017 AForm 4 → | Nov 17, 5:04 pm EST | Natalie C. HollesSenior Vice President, COO | 100,000 | — | — | 100,000 | — | |
| Nov 16, 2017 AForm 4 → | Nov 17, 5:04 pm EST | John T. GraySVP, Chief Scientific Officer | 75,000 | — | — | 75,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:08 pm EDT | Stephen P SquintoDirector | 9,000 | — | — | 9,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:07 pm EDT | Julie SmithDirector | 9,000 | — | — | 9,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:06 pm EDT | Thomas J. SchuetzDirector | 9,000 | — | — | 9,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:05 pm EDT | Kush ParmarDirector | 9,000 | — | — | 9,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:05 pm EDT | Scott W MorrisonDirector | 9,000 | — | — | 9,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:04 pm EDT | Louis G LangeDirector | 9,000 | — | — | 9,000 | — | |
| Oct 8, 2017 AForm 4 → | Oct 10, 6:03 pm EDT | Jennifer JarrettDirector | 9,000 | — | — | 9,000 | — | |
| Oct 2, 2017 MForm 4 → | Oct 4, 8:25 pm EDT | Matthew R PattersonPresident & CEO, Director | 10,000 | — | — | 199,750 | — | |
| Sep 27, 2017 MForm 4 → | Sep 29, 5:48 pm EDT | David NaglerSVP, HR & Corp. Affairs | 3,750 | — | — | 37,347 | — | |
| Sep 15, 2017 MForm 4 → | Sep 19, 6:00 pm EDT | Matthew R PattersonPresident & CEO, Director | 10,000 | — | — | 209,750 | — | |
| Sep 15, 2017 MForm 4 → | Sep 19, 5:59 pm EDT | David NaglerSVP, HR & Corp. Affairs | 3,750 | — | — | 41,097 | — | |
| Sep 7, 2017 XForm 4 → | Sep 11, 2:16 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 5,000 | — | — | 0 | — | |
| Sep 1, 2017 MForm 4 → | Sep 1, 5:55 pm EDT | Suyash PrasadSenior VP & Chief Med Officer | 8,000 | — | — | 88,870 | — | |
| Aug 24, 2017 MForm 4 → | Aug 25, 4:17 pm EDT | Mary NewmanSVP, Regulatory Affairs | 10,000 | — | — | 43,817 | — | |
| Jun 12, 2017 AForm 4 → | Jun 13, 5:23 pm EDT | Jennifer JarrettDirector | 18,000 | — | — | 18,000 | — | |
| May 31, 2017 MForm 4 → | Jun 1, 4:31 pm EDT | Natalie C. HollesSenior Vice President, COO | 20,000 | — | — | 169,819 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:12 pm EST | Thomas P SolowaySenior Vice President, CFO | 80,000 | — | — | 80,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:10 pm EST | Suyash PrasadSenior VP & Chief Med Officer | 70,000 | — | — | 70,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:09 pm EST | Matthew R PattersonPresident & CEO, Director | 200,000 | — | — | 200,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:08 pm EST | Mary NewmanSVP, Regulatory Affairs | 50,000 | — | — | 50,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:08 pm EST | David NaglerSVP, HR & Corp. Affairs | 50,000 | — | — | 50,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:06 pm EST | Natalie C. HollesSenior Vice President, COO | 115,000 | — | — | 115,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:06 pm EST | John T. GraySenior Vice President, R & D | 70,000 | — | — | 70,000 | — | |
| Jan 1, 2017 AForm 4 → | Jan 5, 6:15 pm EST | Julie SmithDirector | 18,000 | — | — | 18,000 | — | late |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:55 pm EDT | Thomas WoiwodeDirector | 18,000 | — | — | 18,000 | — | |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:54 pm EDT | Stephen P SquintoDirector | 9,000 | — | — | 9,000 | — | |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:53 pm EDT | Jonathan SilversteinDirector, 10% Owner | 18,000 | — | — | 18,000 | — | |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:53 pm EDT | Thomas J. SchuetzDirector | 9,000 | — | — | 9,000 | — | |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:52 pm EDT | Kush ParmarDirector | 18,000 | — | — | 18,000 | — | |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:51 pm EDT | Scott W MorrisonDirector | 9,000 | — | — | 9,000 | — | |
| Aug 24, 2016 AForm 4 → | Aug 25, 9:51 pm EDT | Louis G LangeDirector | 18,000 | — | — | 18,000 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:09 pm EDT | Thomas WoiwodeDirector | 1,771,832 | — | — | 0 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:08 pm EDT | Versant Ventures IV, LLC10% Owner | 1,771,832 | — | — | 0 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:08 pm EDT | Jonathan SilversteinDirector, 10% Owner | 4,544,066 | — | — | 0 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:07 pm EDT | ORBIMED ADVISORS LLCDirector, 10% Owner | 4,544,066 | — | — | 0 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:07 pm EDT | Louis G LangeDirector | 24,633 | — | — | 0 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 5:06 pm EDT | 5AM Partners III, LLC10% Owner | 2,322,131 | — | — | 0 | — | |
| Jul 25, 2016 CForm 4 → | Jul 25, 12:19 pm EDT | James E Flynn +510% Owner | 1,003,654 | — | — | 0 | — |